Company / Cash per Share
AYTU BIOPHARMA, INC Cash per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$5.18
FY2025
5-year range
$0.70 / $11.92
FY2021-FY2025
Trend
+42.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 10 years, ranging from $0.70 in FY2022 to $170.03 in FY2018.
Based on SEC 10-K filings.
5.18 in FY2025 with a 10-year CAGR of +18.7%.
Declined from $11.92 to $5.18 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +94.5%
- 5-Year CAGR
- +13.6%
- 10-Year CAGR
- +18.7%
Key checks
Key Insights
- In FY2025, cash per share increased 42.9% year-over-year.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.18 | +42.9% |
| FY2024 | $3.63 | -69.6% |
| FY2023 | $11.92 | +1592.0% |
| FY2022 | $0.70 | -82.2% |
| FY2021 | $3.95 | +43.9% |
| FY2020 | $2.74 | -98.4% |
| FY2018 | $170.03 | +3864.9% |
| FY2017 | $4.29 | -36.7% |
| FY2016 | $6.78 | +628.3% |
| FY2015 | $0.93 | +55.1% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026